Literature DB >> 12974762

Circulating adiponectin levels during human endotoxaemia.

P Keller1, K Møller, K S Krabbe, B K Pedersen.   

Abstract

Adiponectin, an adipocytokine secreted by fat tissue, may prevent development of diabetes type II, as high adiponectin levels are linked with insulin sensitivity. In contrast, tumour necrosis factor (TNF)-alpha, which is also produced by fat tissue, leads to insulin resistance and furthermore inhibits adiponectin mRNA production and secretion of the protein. However, adiponectin also negatively regulates TNF-alpha levels. Therefore, we set out to test whether an infusion of endotoxin would influence circulating adiponectin levels in healthy human subjects. Twenty-three healthy human subjects were injected with endotoxin (2 ng/kg body weight); eight of these subjects were also injected with saline and served as controls. Plasma levels of adiponectin, TNF-alpha and interleukin-6 were measured at 0, 1.5, 2, 4, 8 and 24 h. TNF-alpha and interleukin-6 levels peaked at 1.5 h and 2 h, respectively. Control subjects injected with saline showed a decrease in adiponectin plasma levels with time (P < 0.05) presumably owing to the effect of fasting or physical inactivity. However, there was no change in adiponectin plasma levels in endotoxin injected subjects, thus the effect of fasting was opposed. In conclusion, circulating adiponectin levels are reduced during a resting and fasting state, an effect reversed by endotoxin injection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974762      PMCID: PMC1808829          DOI: 10.1046/j.1365-2249.2003.02264.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Ageing is associated with a prolonged fever response in human endotoxemia.

Authors:  K S Krabbe; H Bruunsgaard; C M Hansen; K Møller; L Fonsmark; J Qvist; P L Madsen; G Kronborg; H O Andersen; P Skinhøj; B K Pedersen
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.

Authors:  A Kappes; G Löffler
Journal:  Horm Metab Res       Date:  2000 Nov-Dec       Impact factor: 2.936

3.  Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway.

Authors:  N Ouchi; S Kihara; Y Arita; Y Okamoto; K Maeda; H Kuriyama; K Hotta; M Nishida; M Takahashi; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

4.  The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor.

Authors:  L Shapiro; P E Scherer
Journal:  Curr Biol       Date:  1998-03-12       Impact factor: 10.834

5.  Insulin resistance and substrate utilization in human endotoxemia.

Authors:  A O Agwunobi; C Reid; P Maycock; R A Little; G L Carlson
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.

Authors:  T Yokota; K Oritani; I Takahashi; J Ishikawa; A Matsuyama; N Ouchi; S Kihara; T Funahashi; A J Tenner; Y Tomiyama; Y Matsuzawa
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

7.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.

Authors:  N Ouchi; S Kihara; Y Arita; K Maeda; H Kuriyama; Y Okamoto; K Hotta; M Nishida; M Takahashi; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

8.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.

Authors:  Norikazu Maeda; Iichiro Shimomura; Ken Kishida; Hitoshi Nishizawa; Morihiro Matsuda; Hiroyuki Nagaretani; Naoki Furuyama; Hidehiko Kondo; Masahiko Takahashi; Yukio Arita; Ryutaro Komuro; Noriyuki Ouchi; Shinji Kihara; Yoshihiro Tochino; Keiichi Okutomi; Masato Horie; Satoshi Takeda; Toshifumi Aoyama; Tohru Funahashi; Yuji Matsuzawa
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

9.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.

Authors:  J Fruebis; T S Tsao; S Javorschi; D Ebbets-Reed; M R Erickson; F T Yen; B E Bihain; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

View more
  14 in total

1.  Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.

Authors:  Jennifer Kaplan; Marchele Nowell; Ranjit Chima; Basilia Zingarelli
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

Review 2.  Adipocyte, adipose tissue, and infectious disease.

Authors:  Mahalia S Desruisseaux; Maria E Trujillo; Herbert B Tanowitz; Philipp E Scherer
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  Adipose tissue, diabetes and Chagas disease.

Authors:  Herbert B Tanowitz; Linda A Jelicks; Fabiana S Machado; Lisia Esper; Xiaohua Qi; Mahalia S Desruisseaux; Streamson C Chua; Philipp E Scherer; Fnu Nagajyothi
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

4.  Circulating YKL-40 levels during human endotoxaemia.

Authors:  J S Johansen; K S Krabbe; K Møller; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

5.  Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock.

Authors:  Jennifer M Kaplan; Alvin Denenberg; Marie Monaco; Marchele Nowell; Hector Wong; Basilia Zingarelli
Journal:  Intensive Care Med       Date:  2009-09-17       Impact factor: 17.440

6.  Chagas disease, adipose tissue and the metabolic syndrome.

Authors:  Fnu Nagajyothi; Mahalia S Desruisseaux; Louis M Weiss; Streamson Chua; Chris Albanese; Fabiana S Machado; Lisia Esper; Michael P Lisanti; Mauro M Teixeira; Philipp E Scherer; Herbert B Tanowitz
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

7.  Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Sun Kwon Kim; Francesca Gotsch; Ronald Lamont; Giovanna Ogge; Percy Pacora; Luis Goncalves; Chong Jai Kim; Ricardo Gomez; Jimmy Espinoza; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2010       Impact factor: 1.901

8.  A single bout of downhill running transiently increases HOMA-IR without altering adipokine response in healthy adult women.

Authors:  A Z Jamurtas; A Garyfallopoulou; A A Theodorou; A Zalavras; V Paschalis; C K Deli; M G Nikolaidis; I G Fatouros; Y Koutedakis
Journal:  Eur J Appl Physiol       Date:  2013-09-26       Impact factor: 3.078

9.  Changes in serum adiponectin concentrations in critical illness: a preliminary investigation.

Authors:  Bala Venkatesh; Ingrid Hickman; Janelle Nisbet; Jeremy Cohen; John Prins
Journal:  Crit Care       Date:  2009-07-02       Impact factor: 9.097

10.  Perspectives on adipose tissue, chagas disease and implications for the metabolic syndrome.

Authors:  Fnu Nagajyothi; Mahalia S Desruisseaux; Linda A Jelicks; Fabiana S Machado; Streamson Chua; Philipp E Scherer; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.